These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17944864)

  • 1. Manipulation of fatty acid amide hydrolase functional activity alters sensitivity and dependence to ethanol.
    Vinod KY; Sanguino E; Yalamanchili R; Manzanares J; Hungund BL
    J Neurochem; 2008 Jan; 104(1):233-43. PubMed ID: 17944864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference.
    Hansson AC; Bermúdez-Silva FJ; Malinen H; Hyytiä P; Sanchez-Vera I; Rimondini R; Rodriguez de Fonseca F; Kunos G; Sommer WH; Heilig M
    Neuropsychopharmacology; 2007 Jan; 32(1):117-26. PubMed ID: 16482090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
    Falenski KW; Thorpe AJ; Schlosburg JE; Cravatt BF; Abdullah RA; Smith TH; Selley DE; Lichtman AH; Sim-Selley LJ
    Neuropsychopharmacology; 2010 Jul; 35(8):1775-87. PubMed ID: 20357755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of alcohol escalation and "relapse" drinking by pharmacological FAAH inhibition in male and female C57BL/6J mice.
    Zhou Y; Schwartz BI; Giza J; Gross SS; Lee FS; Kreek MJ
    Psychopharmacology (Berl); 2017 Oct; 234(19):2955-2970. PubMed ID: 28730283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.
    Seillier A; Advani T; Cassano T; Hensler JG; Giuffrida A
    Int J Neuropsychopharmacol; 2010 Apr; 13(3):373-86. PubMed ID: 19607756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent differences of repeated administration with Delta9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen.
    Corchero J; Romero J; Berrendero F; Fernandez-Ruiz J; Ramos JA; Fuentes JA; Manzanares J
    Brain Res Mol Brain Res; 1999 Apr; 67(1):148-57. PubMed ID: 10101241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout mice.
    Basavarajappa BS; Yalamanchili R; Cravatt BF; Cooper TB; Hungund BL
    Neuropharmacology; 2006 Jun; 50(7):834-44. PubMed ID: 16448676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased ethanol intake in prodynorphin knockout mice is associated to changes in opioid receptor function and dopamine transmission.
    Femenía T; Manzanares J
    Addict Biol; 2012 Mar; 17(2):322-37. PubMed ID: 21966993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit.
    Slivicki RA; Saberi SA; Iyer V; Vemuri VK; Makriyannis A; Hohmann AG
    J Pharmacol Exp Ther; 2018 Dec; 367(3):551-563. PubMed ID: 30275151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception.
    Naidu PS; Booker L; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2009 Apr; 329(1):48-56. PubMed ID: 19118134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.
    Slivicki RA; Xu Z; Mali SS; Hohmann AG
    Pharmacol Res; 2019 Apr; 142():267-282. PubMed ID: 30739035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
    Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
    Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.
    Haller VL; Stevens DL; Welch SP
    Eur J Pharmacol; 2008 Dec; 600(1-3):50-8. PubMed ID: 18762181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene transcription alterations associated with decrease of ethanol intake induced by naltrexone in the brain of Wistar rats.
    Oliva JM; Manzanares J
    Neuropsychopharmacology; 2007 Jun; 32(6):1358-69. PubMed ID: 17063152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase.
    Naidu PS; Kinsey SG; Guo TL; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2010 Jul; 334(1):182-90. PubMed ID: 20375198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kappa- and delta-opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1 receptor knockout mice.
    Urigüen L; Berrendero F; Ledent C; Maldonado R; Manzanares J
    Eur J Neurosci; 2005 Oct; 22(8):2106-10. PubMed ID: 16262648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice.
    Kinsey SG; Naidu PS; Cravatt BF; Dudley DT; Lichtman AH
    Pharmacol Biochem Behav; 2011 Oct; 99(4):718-25. PubMed ID: 21740924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
    Fidelman S; Mizrachi Zer-Aviv T; Lange R; Hillard CJ; Akirav I
    Eur Neuropsychopharmacol; 2018 May; 28(5):630-642. PubMed ID: 29519609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.
    Russo R; Loverme J; La Rana G; Compton TR; Parrott J; Duranti A; Tontini A; Mor M; Tarzia G; Calignano A; Piomelli D
    J Pharmacol Exp Ther; 2007 Jul; 322(1):236-42. PubMed ID: 17412883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice.
    Nozaki C; Markert A; Zimmer A
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1388-96. PubMed ID: 25910421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.